WNT5A and B-cell non-Hodgkin lymphoma: However, in hematological malignancies, including B-cell lymphoma, WNT5A acts as a tumor suppressor able to antagonize the WNT/β-catenin signaling30–32 and it is found silenced by tumor-specific methylation.